James Cave (@JAHCave) header
James Cave (@JAHCave) profile picture

Editor in chief of Drug & Therapeutics Bulletin. Tweeting in a personal capacity.

Joined May 2009
Photo by James Cave (@JAHCave)Photo by James Cave (@JAHCave)Photo by James Cave (@JAHCave)Photo by James Cave (@JAHCave)Photo by James Cave (@JAHCave)Photo by James Cave (@JAHCave)Photo by James Cave (@JAHCave)Photo by James Cave (@JAHCave)Photo by James Cave (@JAHCave)Photo by James Cave (@JAHCave)
James Cave retweeted
Medicines and global warming: a complex problem Read the editorial by @JAHCave on why it's not just about swapping to dry powder inhalers and the importance of taking a holistic approach to tackling the issue. bit.ly/4a5ZiIy
1
112
James Cave retweeted
Redaction at the heart of NICE appraisals In the September editorial @JAHCave takes NICE to task over the amount of information that is redacted in its technical appraisals. bit.ly/3ODzV9s
1
2
1,026
James Cave retweeted
We are very pleased to learn that Australian Prescriber will resume publishing from its new home with Therapeutic Guidelines Limited. We look forward to reading the next issue. https://nitter.cf/t.co/nfxEcQAKl9
1
1
714
James Cave retweeted
Top 10 Thursday A countdown of the most accessed articles from 2022 6. What dose of paracetamol for people with low bodyweight? (DTB Select) https://nitter.cf/t.co/DULxajNbRc
1
557
James Cave retweeted
What does the TIME study tell us about morning and evening dosing of antihypertensive medication? Read our commentary on the TIME study. https://nitter.cf/t.co/dGsbmoriOc
1
189
Women in England will be able to get a year's worth of HRT for the cost of two single prescription charges (i.e. £18.70) from the 1 April
4
3
1
28
9,427
Thank you Dr Bunting for demonstrating the lazy reporting from some sections of the media. @Telegraph @lauradonnlee @Laura__Farris @NHSEngland
2
7
James Cave retweeted
We hope you have had a good week. Why not make it even better with a 25% discount on a DTB subscription for new subscribers? #DTB60 #independent #therapeutics https://nitter.cf/t.co/qrrwm8KHsQ
1
1
There is huge value in continuity of care. Value for the patient Value for the clinician Value for the health serve. So why isn’t it the number one priority for systems? @MartinRCGP @NHSEngland #woncaeurope2022
5
33
4
70
James Cave retweeted
Don't want to miss out on new content from DTB? Sign up to receive an email alert when new articles are published online. We can also send you our electronic table of contents when a new issue is published. ow.ly/UHjS50GrqAC
1
1
Such an important piece of work. The @AHSNNetwork and @PRIMISatUoN collaboration did a great thing. So proud to have been involved and v grateful for the hard work done by AHSNs, CCGs, GP practices. 👏👏Medication safety.
We’re delighted that the #PINCER national rollout led by PRIMIS in collaboration with the AHSN Network features as a case study in the @HealthFdn report "Developing learning health systems in the UK: Priorities for action." health.org.uk/publications/r…
6
25
James Cave retweeted
Challenging pharma: who cares? Professor Fugh-Berman (@Pharmed_Out) and Mike Wilcock discuss Pharma-critical groups, organisations and individuals and the need to counteract misinformation and overpromotion of medicines by the pharmaceutical industry. https://nitter.cf/t.co/sXGNBkMNKr
James Cave retweeted
Please can we have 32 minutes and 10 seconds of your time? DTB's October podcast is available from all good podcast providers. This month we discuss two freebies, advertising woes, paracetamol (again) and standing up to Pharma. https://nitter.cf/t.co/6cZbKGYuBi
1
3
James Cave retweeted
Another NICE drug appraisal that reads more like an MI6 document. #brolucizumab #TA10794 #novartis
James Cave retweeted
Brolucizumab is apparently more cost effective- here are the figures: #NICE #novartis
James Cave retweeted
Disclosure of pharma payments to healthcare professionals in the UK and the rest of Europe lags behind the US. Read our summary of a study that assessed drug company payment disclosure schemes across Europe (https://nitter.cf/t.co/gfGFNKYRpa) and why it matters (https://nitter.cf/t.co/8PN32w7dow).
James Cave retweeted
Did you know that DTB has a series of topic collections to help you find content of interest? https://nitter.cf/t.co/Ymd1DYWxoR
James Cave retweeted
CQC guidance (https://nitter.cf/t.co/Gt5uP9ZEhp) for General Practice includes advice on what emergency medicines should be available for home visits. We covered this topic in two articles in 2015 (https://nitter.cf/t.co/F92IlNFWsm and https://nitter.cf/t.co/LmJYFZX1fp). Both are free to access for 3 months.
Clear (as mud) on their website that we need to risk assess drugs we decide not to stock based on an article from @DTB_BMJ which is behind a paywall 😩 cqc.org.uk/guidance-provider…
1
1
James Cave retweeted
⚠️ Safety update: metformin and vitamin B12 deficiency ⚠️ Read our summary of the MHRA's advice on monitoring vitamin B12 levels in people taking metformin. https://nitter.cf/t.co/GS6BzdY1o6
7
2
15
James Cave retweeted
The BNF is published by the Royal Pharmaceutical Society and BMJ. Twice a year, the BNF editorial team provide DTB with a summary of some key changes to BNF content. These include new drug monographs, updated monographs and safety updates. ⬇️ https://nitter.cf/t.co/dNxshy5MyK
2
3